肽基转移酶
核糖体
化学
生物膜
特洛伊木马
静电学
阳离子聚合
特洛伊木马
细菌
静电
诱饵
组合化学
抗菌剂
微生物学
生物
核糖体RNA
血浆蛋白结合
蛋白质结构
生物化学
蛋白质-蛋白质相互作用
纳米技术
生物物理学
限制
作者
Lei Tian,Boxin Zhang,Bingxing Zhang,Jinrong Hu,Changhua Ke,Yunfei Zhang,Jingjing Zhou,Hui Xiong,Juan Xia,Jiang Nan,Mengzhou Wang,Zhiyou Yang,Bin Tian,Qianqian Zhao,Wenliang Wang,Xu Zhao,Taotao Qiang,Chengyuan Liang
标识
DOI:10.1021/acsinfecdis.5c01027
摘要
Antimicrobial resistance threatens health, and new agents are needed. Lefamulin is the only approved antibiotic of a new class in two decades. It targets the 50S peptidyl transferase center (PTC). Its efficacy against multidrug-resistant pathogens is limited by anionic envelopes, limiting penetration. We report a charge-anchored pleuromutilin exploiting an electrostatic Trojan horse to breach barriers and engage the ribosome. An N-pyridinium provides a cationic localizer. A two-step mechanism operates. Long-range electrostatics enrich ligands at anionic interfaces and the PTC. Short-range interactions secure high-affinity placement of the tricyclic core. Computer simulations support the occupancy of the activity pocket and the field-guided orientation of the cationic side chain for PNY-6b. Proteomics highlights ribosomal proteins as dominant targets. Cellular assays show biofilm eradication and membrane depolarization. In murine infections, PNY-6b lowers burden and improves survival. Electrostatic complementarity offers a generalizable design principle for targets with electrostatic fields and for pathogens with poor envelope permeability.
科研通智能强力驱动
Strongly Powered by AbleSci AI